Puertas, Borja; González-Calle, Verónica; Sureda, Anna; Moreno, María-José; Oriol, Albert; González, Esther; Rosiñol, Laura; López, Jordi; Escalante, Fernando; Martínez-López, Joaquín; Carrillo, Estrella; Clavero, Esther; Ríos-Tamayo, Rafael; Rey-Bua, Beatriz; González-Rodríguez, Ana-Pilar; Dourdil, Victoria; de-Arriba-de-la-Fuente, Felipe; González, Sonia; Pérez-de-Oteyza, Jaime; Hernández-García, Miguel-Teodoro; García-Mateo, Aranzazu; Bargay, Joan; Blade, Joan; Lahuerta, Juan-José; San-Miguel, Jesus-F; Ocio, Enrique-M; Mateos, María-Victoria
(FERRATA STORTI FOUNDATION, 2023-10)
In this randomized phase II study (GEM-KyCyDex, clinicaltrials gov. Identifier: NCT03336073), the combination of weekly carfilzomib 70 mg/m2, cyclophosphamide and dexamethasone (KCd) was compared to carfilzomib and ...